Off-the-shelf vaccine shows early promise against pancreatic and colorectal cancer recurrence, with vaccine-induced immune responses correlating with longer cancer-free survival.
Off-the-shelf vaccine shows early promise against pancreatic and colorectal cancer recurrence, with vaccine-induced immune responses correlating with longer cancer-free survival.